MARSHALL WACE, LLP - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$513,655
+35.1%
143,479
+24.9%
0.00%0.0%
Q1 2023$380,319
-92.2%
114,900
-95.4%
0.00%
-96.2%
Q4 2020$4,857,000
-18.4%
2,490,9000.0%0.03%
-31.6%
Q3 2020$5,953,000
+123.5%
2,490,900
+174.0%
0.04%
+100.0%
Q2 2020$2,663,000
+7.2%
908,926
+5.4%
0.02%
-24.0%
Q1 2020$2,484,000862,3920.02%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders